India's leading pharmaceutical companies, including Zydus Cadila and Ipca Laboratories, have started increasing production of the antimalarial drug hydroxychloroquine (HCQ), which has been touted by U.S. President Donald Trump and others as a potential treatment for COVID-19. Its status in regards to COVID-19 remains a topic of debate among health professionals.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!